Canada Pension Plan Investment Board’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,600
Closed -$147K 1806
2025
Q4
$147K Buy
+5,600
New +$145K ﹤0.01% 1741
2025
Q3
Sell
-80,400
Closed -$1.6M 1399
2025
Q2
$1.6M Buy
+80,400
New +$1.57M ﹤0.01% 913
2024
Q4
Sell
-3,200
Closed -$69.5K 1441
2024
Q3
$69.5K Hold
3,200
﹤0.01% 1211
2024
Q2
$62.8K Buy
+3,200
New +$66.8K ﹤0.01% 1247
2022
Q2
Sell
-88
Closed -$6K 1306
2022
Q1
$6K Sell
88
-2,890
-97% -$190K ﹤0.01% 1289
2021
Q4
$300K Buy
2,978
+2,363
+384% +$208K ﹤0.01% 1173
2021
Q3
$55K Buy
+615
New +$55.9K ﹤0.01% 1294

Other funds holding FLGT

Canada Pension Plan Investment Board's FLGT Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 5,600 shares — an estimated $147K sold.

Canada Pension Plan Investment Board first reported a position in FLGT in Q3 2021 and held it in 7 quarters. The position peaked at $1.6M in Q2 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 5,600 Fulgent Genetics shares in Q1 2026, an estimated $147K.
  • Canada Pension Plan Investment Board first reported a position in Fulgent Genetics in Q3 2021 and held it in 7 quarters.
  • Canada Pension Plan Investment Board's Fulgent Genetics position peaked at $1.6M in Q2 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.